# Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

> **NCT04727723** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 164 (actual)

## Conditions studied

- Gastroenteropancreatic Neuroendocrine Tumor

## Interventions

- **DRUG:** Lutathera®

## Key facts

- **NCT ID:** NCT04727723
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2026-03-10
- **Final completion:** 2026-03-10
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727723, "Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04727723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*